[HTML][HTML] Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases

Y Cheng, X Ma, Y Wei, XW Wei - … et Biophysica Acta (BBA)-Reviews on …, 2019 - Elsevier
The chemokine receptor CXCR2 and its ligands are implicated in the progression of tumours
and various inflammatory diseases. Activation of the CXCLs/CXCR2 axis activates multiple …

[HTML][HTML] Target specific tight junction modulators

J Brunner, S Ragupathy, G Borchard - Advanced drug delivery reviews, 2021 - Elsevier
Intercellular tight junctions represent a formidable barrier against paracellular drug
absorption at epithelia (eg, nasal, intestinal) and the endothelium (eg, blood–brain barrier) …

A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells

G Yi, M Liang, M Li, X Fang, J Liu, Y Lai, J Chen… - Inflammation …, 2018 - Springer
Background Chronic obstructive pulmonary disease (COPD) is a chronic and progressive
lung disease characterized by a mixture of small airway disease and lung tissue …

An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases

S Silnitsky, SJS Rubin, M Zerihun, N Qvit - International Journal of …, 2023 - mdpi.com
Protein kinases are one of the most significant drug targets in the human proteome,
historically harnessed for the treatment of cancer, cardiovascular disease, and a growing …

PKCζ, MMP‑2 and MMP‑9 expression in lung adenocarcinoma and association with a metastatic phenotype

X Cai, H Zhu, Y Li - Molecular medicine reports, 2017 - spandidos-publications.com
The aim of the present study was to investigate protein kinase C ζ type (PKCζ), matrix
metalloproteinase (MMP)‑2 and MMP‑9 expression in lung adenocarcinoma and to define …

[HTML][HTML] Surfaxin attenuates PM2. 5-induced airway inflammation via restoring surfactant proteins in rats exposed to cigarette smoke

XW Sun, YN Lin, YJ Ding, SQ Li, HP Li, JP Zhou… - Environmental …, 2022 - Elsevier
Epidemiologic studies have shown that the fine particulate matter 2.5 (PM2. 5) exaggerates
chronic airway inflammation involving in acute exacerbation of chronic obstructive …

PRKCD as a potential therapeutic target for chronic obstructive pulmonary disease

S Li, Q Huang, D Zhou, B He - International immunopharmacology, 2022 - Elsevier
Background Chronic obstructive pulmonary disease (COPD) is a common respiratory
disease characterized by progressive airflow limitation and abnormal lung function due to …

[HTML][HTML] Impact of peptide permeation enhancer on tight junctions opening cellular mechanisms

J Brunner, D Schvartz, A Gouiller, A Hainard… - … and Biophysics Reports, 2022 - Elsevier
The myristoylated pentapeptide, L-R5, contains an amino acid sequence of the zeta
inhibitory peptide (ZIP) portion (pseudosubstrate) of protein kinase C zeta (PKC ζ). As PKC ζ …

Verproside, the Most Active Ingredient in YPL-001 Isolated from Pseudolysimachion rotundum var. subintegrum, Decreases Inflammatory Response by Inhibiting …

ES Oh, HW Ryu, MO Kim, JW Lee, YN Song… - International Journal of …, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease
which causes breathing problems. YPL-001, consisting of six iridoids, has potent inhibitory …

Mechanical strain mimicking breathing amplifies alterations in gene expression induced by SiO2 NPs in lung epithelial cells

C Schmitz, J Welck, I Tavernaro, M Grinberg… - …, 2019 - Taylor & Francis
The effects of engineered nanomaterials on human health are still intensively studied in
order to facilitate their safe application. However, relatively little is known how mechanical …